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Background: The marine environment is a unique source of bioactive natural products, of which Sargassum
muticum (Yendo) Fensholt is an important brown algae distributed in Jeju Island, Korea. S. muticum is a traditional
Korean food stuff and has pharmacological functions including anti-inflammatory effects. However, the active
ingredients from S. muticum have not been characterized.
Methods: Bioguided fractionation of the ethanolic extract of S. muticum, collected from Jeju island, led to the isolation
of a norisoprenoid. Its structure was determined by analysis of the spectroscopic data. In vitro anti-inflammatory activity
and mechanisms of action of this compound were examined using lipopolysaccharide (LPS)-stimulated RAW 264.7 cells
through ELISA assays and Western blot analysis.
Results: Apo-9′-fucoxanthinone, belonging to the norisoprenoid family were identified. Apo-9′-fucoxanthinone
effectively suppressed LPS-induced nitric oxide (NO) and prostaglandin E2 (PGE2) production. This compound also
exerted their anti-inflammatory actions by down-regulating of NF-κB activation via suppression of IκB-α in
macrophages.
Conclusions: This is the first report describing effective anti-inflammatory activity for apo-9’-fucoxanthinone′-fucoxanthnone
isolated from S. muticum. Apo-9′-fucoxanthinonemay be a good candidate for delaying the progression of human
inflammatory diseases and warrants further studies.
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Inflammation is the response of an organism to invasion
by foreign pathogens such as parasites, bacteria and vi-
ruses. The inflammatory response is an important pro-
tective reaction to injury, irritation and infection and is
characterised by redness, heat, swelling, loss of function
and pain [1]. In the inflammatory state, activated im-
mune cells, such as macrophages secrete large amounts
of proinflammatory cytokines, nitric oxide (NO), and
prostaglandin E2 (PGE2). However, high levels of NO
and PGE2 in a chronic inflammation state can result in
various pathological conditions [1-4]. For this reason,
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reproduction in any medium, provided the ormacrophages are current research topics for the devel-
opment of new anti-inflammatory agents. There have
been many attempts to derive new anti-inflammatory
agents from natural compounds [5-7]. Traditional rem-
edies derived from terrestrial plants and maritime
plants such as seaweeds have been considered safe,
less toxic, and readily available, even through their
modes of action are yet infinite for the most part.
Thus, uncovering the molecular mechanism under-
lying the biological function of natural products might
be a good strategy for identifying new therapeutic
agents [8,9].
Sargassum muticum (Yendo) Fensholt, a brown alga,
is the most important economic seaweed, and widely
distributed on the seashore of southern and eastern
Korea. It is commonly consumed as a popular marine
vegetable for more than 1000 years in Korea, particularly
in Jeju Island. It has various biological activities, including
antioxidant, anti-inflammatory, and antibacterial activitiesd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Apo-9’-fucoxanthinone
Figure 1 L The structure of Apo-9′-fucoxanthinone.
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anti-inflammatory properties of various seaweads [11-14].
During our on-going screening program designed
to identify the anti-inflammatory potential of natural
compounds, we have isolated apo-9′-fucoxanthinone
from S. muticum, using activity-directed fraction-
ation, and characterized apo-9′-fucoxanthinone’s
structural identity using spectroscopy (1H and
13NMR) in this study. Also, as a prelude to revealing
the anti-inflammatory effects and its mechanisms of
apo-9′-fucoxanthinone, the present study focused on
whether apo-9′-fucoxanthinone inhibited the produc-
tion of NO and PGE2 and expression of inducible ni-
tric oxide synthase (iNOS) and cyclooxygenase
(COX)-2 in LPS-stimulated macrophages.Methods
Extraction and isolation of apo-9′-fucoxanthinone
S. muticum was collected from the coasts of Jeju Island
in March 2009, and verified by Dr. Wook Jae Lee at Jeju
Technopark (JTP). A voucher specimen (CSC-002) was
deposited at Department of Chemistry, Jeju National
University, Jeju, Korea. S. muticum were washed 3 times
with water to remove any salt, epiphytes, and sand
attached to the surface. They were dried at 60°C for
24 h in an oven, and pulverized in a grinder prior to
extraction. The dried powder (800 g) was extracted
with 70% aqueous ethanol with stirring for 2 days
at room temperature. The filtrate was concentrated
under reduced pressure. The extract (105 g) was
suspended in water (1.0 L), and successively
partitioned into n-hexane, methylene chloride, ethyl
acetate, and n-butanol fractions. The fraction of
methylene chloride (7 g), being dissolved in solvent,
mixed with celite, and evaporated using a rotary
vacuum evaporator. After lyophilization, it was
chromatographed and eluted by using the solvents
500 mL of into n-hexane, methylene chloride/ethyl
acetate (10:1, 5:1, 2:1), methylene chloride, ethyl acet-
ate, and methanol in order. The hexane fraction was
chromatographed over a silica gel column using
n-hexane:EtOAc (3:1) in order to obtain 10 sub-
fractions (F-1 to F-10). All fractions containing the
same constituent(s) identified on the TLC plates were
combined and the solvents were evaporated using a
rotary vacuum evaporator. Structures of fraction 10 of
them (F10, 2.3 g) were determined using proton-
nuclear magnetic resonance (1H NMR) and 13C NMR.
The compound’s structural identity was determined
by one-and two-dimensional nuclear magnetic reson-
ance (NMR) spectroscopic analysis (Additional file 1)
and comparison to published values. Structures of
these compounds are given in Figure 1.Chemicals and reagents
Dulbecco’s modified Eagle’s medium (DMEM) and foetal
bovine serum (FBS) were obtained from Invitrogen-Gibco
(Grand Island, NY, USA). Enzyme-linked immunosorbent
assay (ELISA) kits for prostaglandin E2 (PGE2) was pur-
chased from R&D Systems, Inc. (St. Louis, MO, USA).
Anti-IκB-α, anti-phosphorylated IκB-α (anti-p-IκB-α) were
purchased from Cell Signaling Technology (Beverly, MA,
USA). Pyrollidine dithiocarbamate (PDTC, a specific in-
hibitor of NF-κB) was purchased from Calbiochem (San
Diego, CA, USA). All other reagents were purchased from
Sigma-Aldrich Chemical Co. (St Louis, MO, USA).
RAW 264.7 cell culture
RAW 264.7 cells were obtained from the Korean Cell Line
Bank (KCLB; Seoul, Korea) and maintained at sub-
confluence in a 95% air, 5% CO2 humidified atmosphere at
37°C as described previously [11-14]. Cells at passages
10–20 were used for the experiments and subcultured
every 2–3 days. The medium for routine sub-cultivation
was DMEM supplemented with FBS (10%), penicillin (100
units/mL), and streptomycin (100 μg/mL). Cells were
counted with a haemocytometer, and the number of viable
cells was assessed by trypan blue dye exclusion method.
MTT assay for cell viability
Cell viability was measured as described previously
[11-14] with slight modification using MTT assay. RAW
264.7 cells were cultured in 96-well plates for 18 h,
followed by treatment with LPS (1 μg/mL) in the presence
of various concentrations of the sample. After a 24-h
incubation, MTT was added to the medium for 4 h. Fi-
nally, the supernatant was removed and the formazan
crystals were dissolved in DMSO. Absorbance was mea-
sured at 540 nm. The percentage of cells showing cyto-
toxicity relative to the control group was determined.
Nitric oxide determination
RAW 264.7 cells were plated at 1.5 × 105 cells/well in 24-well
plates and then incubated with or without LPS (1 μg/mL)
in the absence or presence of various concentrations (12.5,
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Nitrite levels in culture media were determined as described
previously [11-14] with slight modification using the Griess
reaction and presumed to reflect NO levels. Briefly, the
culture supernatant (100 μL) was mixed with the same
volume of Griess reagent (1% sulphanilamide and 0.1%
N-[1-naphthyl]-ethylenediamine dihydrochloride in 5%
phosphoric acid %) for 10 min. Absorbance was the mea-
sured at 540 nm using spectrophotometer. Fresh culture
media were used as blanks in all experiments. NO levels in
samples were read off a standard sodium nitrite curve.
Detection of PGE2 in supernatant
Sandwich ELISA was used to determine the inhibitory
effects of various concentrations (12.5, 25, 50, and
100 μg/mL) of apo-9-fucoxanthinone on the production
of cytokines PGE2 in LPS-treated RAW 264.7 cells.
RAW 264.7 cells were stimulated for 24 h before the
supernatant was harvested and assayed according to the
manufacturer’s protocol for the relevant ELISA kit. Re-
sults from 3 independent experiments were used for
statistical analysis.
Western blot analysis
Western blotting was performed with a SDS-PAGE Elec-
trophoresis System as described previously [11-14]. Briefly,
the RAW 264.7 cells (5.0 × 105 cells/mL) were pre-
incubated for 18 h and then treated with LPS (1 μg/mL)
plus aliquots sample for 24 h. After incubation, the cells
were washed twice with cold PBS. Whole-cell lysates
(25 μg) were separated by 10% sodium dodecyl sulphate-
polyacrylamide gel electrophoresis (SDS-PAGE) and
electro-transferred to a polyvinylidene fluoride (PVDF)
membrane (BIO-RAD, HC, USA). The membrane was
incubated for 24 h with 5% skim milk and then incu-
bated with iNOS (1:2500), COX-2 (1:2500), IκB-α
(1:1000), phosphorylated IκB-α, antibodies (1:1000) at
room temperature for 2 h. The membrane was washed
4 times with TTBS and incubated for 30 min with a
peroxidase-conjugated secondary antibody (1:5000) at
room temperature. Finally, The immunoactive proteins
were detected using an enhanced chemiluminescence
(ECL) Western blotting detection kit (Amersharm
Pharmacia Biotech., NY, USA).
Statistical analysis
Results are presented as the means ± standard deviation
of at least three replicates. The Student t-test was used
for statistical analyses of the difference noted. P values
of 0.05 or less were considered statistically significant.
Results and discussion
Brown algae have proven to be rich sources of structur-
ally novel and biologically active natural compounds inrecent study. These compounds have served as import-
ant chemical prototypes for the discovery of new drugs
for use in the treatment of various human diseases [15].
Brown algae are also very popular sea vegetables, and
many people consider this vegetable as a food of health
benefit in East Asia such as Korea, China, and Japan.
Jeju Island, the largest island in Korea, is located in the
southwest of the Korean Strait, and is well known for its
distinctive environment. In particular, the sea levels
around this island are known to fluctuate rapidly as a re-
sult of global warming. Therefore, in response to this
unusual environment, the brown algae that are present
on Jeju Island may possess substantial endogenous pro-
tective mechanisms [12]. Some studies on brown algae-
derived anti-inflammatory compounds have investigated
potential inhibitory effects by using the LPS-stimulated
murine macrophages [16-18]. Previously, we found that
the a S. muticum extract displayed an appreciable anti-
inflammatory effect in mouse macrophage RAW264.7
cells [11]. In the present study, we isolated the active sub-
stance, in an attempt to understand the possible anti-
inflammatory mechanism of S. muticum. To identify its
active components, the ethanol extract was suspended in
H2O and extracted successively with n-hexane, methylene
chloride, ethyl acetate, and n-butanol. The methylene
chloride fraction was subjected repeatedly to column
chromatography over celite and silica gel in various solv-
ent systems, to yield the active ingradent. It was identified
as apo-9′fucoxanthinone (Figure 1) by comparison of
physical and spectroscopic data with published values.
In murine macrophage RAW264.7 cells, LPS alone in-
duces the transcription and protein synthesis of iNOS and
COX-2, which produce large amounts of NO and PGE2,
respectively. Excess production of NO by iNOS has been
implicated in a wide spectrum of diseases including sep-
tic shock, rheumatoid arthritis, cerebral ischemia, mul-
tiple sclerosis, and diabetes [19]. For this reason, NO
production induced by LPS through iNOS can reflect
the degree of inflammation, and a change in NO level
through inhibition of iNOS enzyme activity or iNOS in-
duction provides a means of assessing the effect of
agents on the inflammatory process. Therefore, the
modulation of macrophage-mediated inflammatory re-
sponses is emerging as a promising new therapeutic ap-
proach against inflammatory diseases [12-14,20,21]. In an
effort to characterize the anti-inflammatory activities of
apo-9′fucoxanthinone, we firstly assessed the effects of
apo-9′fucoxanthinone on LPS induced NO production in
RAW 264.7 cells. Since the half-life of NO is very short,
we used nitrite production as an indicator of NO released
by LPS-activated macrophages. As shown in Figure 2A,
compared to in normal macrophages, NO production in-
creased >15 fold in LPS-activated macrophages. apo-



































Figure 2 Effect of Apo-9′-fucoxanthinone on nitric oxide and PGE2 production in LPS-stimulated RAW264.7 cells. The cells were
stimulated with 1 μg/mL of LPS only or with LPS plus various concentrations (12.5, 25, 50, and 100 μg/mL) of Apo-9′ for 24 hr. Nitric oxide
production was determined by the Griess reagent method. After a 24-h incubation, PGE2 in the culture supernatants was measured by an
enzyme-linked immunosorbent assay (ELISA) kit. Cell viability was determined from the 24 hr culture of cells stimulated with LPS (1 μg/mL) in the
presence of Apo-9′. The data represent the mean ± SD of triplicate experiments.*P < 0.05, **P < 0.01 versus LPS alone.
Yang et al. DARU Journal of Pharmaceutical Sciences 2013, 21:62 Page 4 of 7
http://www.darujps.com/content/21/1/62in a dose-dependent manner: At apo-9′-fucoxanthinone
concentrations of 12.5 μg/mL, 25 μg/mL, 50 μg/mL,
and 100 μg/mL, the production of NO by LPS-treated
macrophages decreased, as compared with LPS-treated
macrophages not treated with apo-9′-fucoxanthinone
(Figure 2A). DMSO, the vehicle control, had no effect
on NO production (data not shown), reconfirming its
immunological inertness. In parallel, the potential cyto-
toxicity of apo-9′-fucoxanthinone was evaluated by an
MTT assay after incubating cells for 24 h in the absence
and presence of LPS. However, cell viability was
negligibly affected at the concentrations used (12.5 μg/
mL, 25 μg/mL, 50 μg/mL, and 100 μg/mL) to inhibit
NO (Figure 2A). Thus, the inhibitory effects of apo-9′-
fucoxanthinone were not attributable to cytotoxicity.To further elucidate the mechanisms by which apo-9′-
fucoxanthinone inhibited NO production in LPS-activated
macrophages, we analyzed apo-9′-fucoxanthinone’s effect
on LPS-induced iNOS gene expression in macrophages.
Under normal conditions, RAW 264.7 cells expressed
non-detectable levels of iNOS mRNA, but iNOS mRNA
levels increased markedly after 24 h of LPS stimulation
(Figure 3A). With the addition of apo-9′-fucoxanthinone
(12.5 μg/mL - 100 μg/mL), dose-dependent inhibition
of iNOS expression was observed, indicating that
apo-9′-fucoxanthinone modulates iNOS expression.
PGE2 is an inflammatory mediator that is produced
from the conversion of arachidonic acid by cyclooxygen-
ase. In a variety of inflammatory cells, including macro-




















































































Figure 3 Effect of Apo-9′-fucoxanthinone on the activation of iNOS and COX-2 in LPS-stimulated RAW 264.7 cells. RAW 264.7 cells (5.0 ×
105 cells/mL) were stimulated with LPS (1 μg/mL) in the Apo-9′ (12.5, 25, 50, and 100 μg/mL) for 24 hr. Whole-cell lysate (25 μg) were prepared


























Figure 4 Effects of Apo-9′-fucoxanthinone on the degradation of IκB-α in LPS stimulated RAW 264.7 cells. RAW 264.7 cells (1.0 × 106 cells/mL)
were stimulated with LPS (1 μg/mL) in the presence of apo-9′-fucoxanthinone (12.5, 25, 50, and 100 μg/mL) or PDTC (40 μM) for 15 min. Whole cell lysates (30 ug) were
prepared and the protein level was subjected to 12% SDS-PAGE, and expression of IkB-α and β-actin were determined by Western blotting. The β-actin antibody as a
loading control.
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amount of PGE2 at inflammatory sites. Numerous studies
have reported that prostaglandin (PGE)2 participate in in-
flammatory and nociceptive events [22-24]. Therefore its
ubiquitous role in the pathogenesis of inflammatory gene
expression, PGE2 is a current target for treating various
diseases. For this reason, we next examined the effects
of apo-9′-fucoxanthinone on PGE2 production in LPS-
stimulated RAW 264.7 macrophages. Cells were pre-
incubated with apo-9′-fucoxanthinone for 1 h, following
which they were stimulated with 1 μg/mL LPS for 24 h.
As shown in Figure 2B, Compared to unstimulated macro-
phages, the PGE2 level increased dramatically by 15-fold
in LPS-stimulated macrophages. With the addition of
apo-9′-fucoxanthinone (12.5 μg/mL, 25 μg/mL, 50 μg/
mL, and 100 μg/mL) a dose-dependent reduction in PGE2
was observed (Figure 2B). In order to determine the
mechanism by which apo-9′-fucoxanthinone reduces
LPS-induced PGE2 production, we studied the ability of
apo-9′-fucoxanthinone to influence the LPS-induced ex-
pression of COX-2. The addition of LPS resulted in a
clearly defined increase in COX-2 expression that was
markedly attenuated in a dose-dependent fashion when
treated with apo-9′-fucoxanthinone (Figure 3B), corrobor-
ating that apo-9′-fucoxanthinone induces a decrease in
COX-2, which translates into a dramatic decrease in PGE2.
NF-κB activation, in response to pro-inflammatory stim-
uli, involves the rapid phosphorylation of IκBs by the IKK
signalosome complex. Free NF-κB produced by this
process translocates to the nucleus, where it binds to κB-
binding sites in the promoter regions of target genes. It
then induces the transcription of pro-inflammatory media-
tors such as iNOS and COX-2. Actually, several studies
have shown that anti-inflammatory agents inhibit the acti-
vation of NF-κB by preventing IκB degradation [25-27].
Thus, we attempted in this study to determine whether or
not apo-9′-fucoxanthinone inhibits the phosphorylation
and degradation of IκB. Accordingly, RAW 264.7 cells
were pretreated for 30 min with 9′fucoxanthinone, and
IκB-α protein levels were determined after 15 min of fur-
ther LPS exposure (1 μg/mL). As shown in Figure 4, apo-
9′-fucoxanthinone was shown to significantly suppress the
LPS-induced IκB-α degradation. As expected, the refer-
ence compounds 2-amino-4-methyl pyridine (iNOS in-
hibitor) also potently inhibited the LPS-induced IκB-α
degradation at 40 μM. These results show that apo-9′-
fucoxanthinone inhibits LPS induced NF-κB activation by
preventing the IκB-α degradation.
Conclusions
The results of this study reveal, for the first time, that the
apo-9′-fucoxanthinone isolated from S. muticum exhibit
anti-inflammatory properties through suppressing NO
and PGE2 production in LPS-stimulated RAW 264.7 cellsby attenuation of NF-κB-mediated iNOS and COX-2 ex-
pression. It is proposed that that apo-9′-fucoxanthinone is
a potential anti-inflammatory agent and may be used in
the future to treat inflammation-associated human health.
To our knowledge, this is the first report concerning the
evaluation of the anti-inflammatory properties of apo-
9′-fucoxanthinone.
Additional file
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